Pneumococcal disease is caused by a bacterium called ... Routine infant vaccination also reduces transmission of the serotypes (variations) of the type of bacteria covered by the vaccines.

A recent analysis of Black and non-Black US adults with pneumococcal disease ... and work location—on the risk of transmission of invasive pneumococcal disease. Visit us on Facebook.

Just one in four (25%) people at high risk of pneumococcal disease, an infection that causes pneumonia—children younger than 2, adults older than 64, and those with certain chronic health ...

The CDC revised its pneumococcal pneumonia shot recommendation, saying there is a substantial increase in the risk for ...

The pneumococcal polysaccharide vaccine (PPV) is currently recommended for older adults and high-risk subjects, including patients with chronic obstructive pulmonary disease (COPD) and asthma.

With Capvaxive, MSD (known as Merck & Co in the US and Canada) is aiming to carve out a niche in the over-50s, positioning it as the go-to vaccine used to prevent invasive pneumococcal disease ...

Vaccination is extremely crucial in reducing morbidity and mortality by protecting billions of people every year from infectious diseases. The key reason the adult population has grown significantly ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

The Centers for Disease Control and Prevention (CDC) recommends that adults ages 65 years or older receive the pneumococcal conjugate vaccination (PCV15 or PCV20). If you receive PCV15 ...

Thanks to epidemiological control and prevention actions as well as to a the weather conditions, the active transmission of ...

The company is adopting a "portfolio strategy" to pneumococcal disease, with "tailored…vaccines to meet the specific needs of different populations," said Dr Eliav Barr, the drugmaker's chief ...